Breakout Sessions III
Take a deeper dive into the topics that matter most to your organization. These interactive sessions are designed to share targeted insights and encourage collaborative discussions.
Beyond The Single Site: Growth Pathways Through SMOs & Site Networks
Scaling a research operation opens new doors — more studies, deeper therapeutic expertise, greater sponsor visibility, and stronger regional influence. For LATAM sites exploring growth, two distinct models offer compelling pathways: site management organizations (SMOs) and site networks. This session examines both, drawing on firsthand experience from LATAM leaders who have navigated each model, so sites can make informed decisions about which path aligns with their goals, capacity, and market context.
Country Roundtable — Argentina, Chile
Argentina and Chile represent two of Latin America’s most established and sponsor-trusted research environments — each with experienced investigator networks, ICH-aligned regulatory frameworks, and strong track records in multi-country trial execution. Together, these two countries represent the leading edge of quality-driven clinical research in Latin America. This roundtable examines how sites in each market can sustain and expand that leadership.
Stronger Together: Supporting Regional Site Collaboration
The most competitive regions in global clinical research are also among the most collaborative — and Latin America has a significant opportunity to build that same regional strength. When sites share best practices, create referral pathways, and advocate collectively, everyone benefits. This session builds a framework for strategic site collaboration: how to establish trust across competing sites, identify what can be shared safely, and create peer networks that generate competitive advantages for the entire region.
What You’re Not Charging For: Missed Costs In Clinical Research Budgets
Sites carry financial burdens that rarely appear in sponsor budgets — currency exchange losses, regulatory resubmission fees, document translation and notarization requirements, import duties on investigational products, and the compounding cost of protocol amendments that trigger entirely new approval processes. These are not edge cases; they are structural features of conducting research in the region. Prepare your site for success with the knowledge of what costs are being absorbed, build it into every budget conversation, and negotiate cost recovery that reflects the true operational reality of running trials in Latin America.